Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents

Jens T Van Praet^{1

2}, Stefaan Vandecasteele¹, Anneleen De Roo³, An S De Vriese^{1

2}, Marijke Reynders⁴

Affiliations

¹ Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
² Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
³ Curando, Ruiselede, Belgium.
⁴ Department of Laboratory Medicine, Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.

Comment

Jens T Van Praet et al. Clin Infect Dis. 2021.

. 2021 Dec 6;73(11):2145-2147.

doi: 10.1093/cid/ciab300.

Jens T Van Praet^{1

2}, Stefaan Vandecasteele¹, Anneleen De Roo³, An S De Vriese^{1

2}, Marijke Reynders⁴

¹ Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
² Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
³ Curando, Ruiselede, Belgium.
⁴ Department of Laboratory Medicine, Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.

No abstract available

Comment on

Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
Capetti AF, Stangalini CA, Borgonovo F, Mileto D, Oreni L, Dedivitiis G, Lupo A, Cossu MV, Bilardo L, Giacomelli A, Galli M, Rizzardini G. Capetti AF, et al. Clin Infect Dis. 2021 Sep 15;73(6):e1402-e1403. doi: 10.1093/cid/ciab214. Clin Infect Dis. 2021. PMID: 33693610 Free PMC article. No abstract available.